Recent presentation by Patrick Frey, the chief of staff in the Office of New Drugs at the US FDA underscores important trends in the biopharmaceutical R&D sector. At the end of November 2017, active INDs were at 7,020, a 14-year record high, at a steady growth since 2004, when the number was 4,361 Breakthrough […]

Dec. 6, 2017  Australian Competition and Consumer Commission, a watchdog organisation,  is taking GlaxoSmithKline and Novartis to court over alleged false marketing of their pain relief gels. The action is part of a crakdown on "misleading representations accross the pharmaceutical industry  

Akili Achieves Primary Efficacy Endpoint in Pediatric ADHD Pivotal Trial Company Completes Large Multi-Center, Randomized, Controlled Study of Novel Digital Medicine and Plans Regulatory Filing AKL-T01, Akili's ADHD treatment in development, is a first-of-its-kind prescription digital medicine being evaluated as a potential treatment for ADHD. (Photo: Business Wire)​ December 04, 2017 02:00  BOSTON–(BUSINESS WIRE)–Akili Interactive (“Akili” […]

LFB : Denis Delval proposé par l’Etat comme nouveau PDG du groupe Publié le mardi 28 novembre 2017 Réuni le 22 novembre 2017, le Conseil d’administration du LFB a convoqué une Assemblée générale des actionnaires pour le 4 décembre 2017 pour proposer la désignation de Denis Delval et Corinne Fau comme administrateurs. Denis Delval a […]

How do cells release IL-1? After 3 decades, now we know Surprising answer could help scientists build better vaccines, treat inflammation Date: November 28, 2017 Source: Boston Children's Hospital Summary: For the first time, researcher shows that the molecule that enables living immune cells to release interleukin-1, key to our innate immune response. The molecule, […]